vimarsana.com
Home
Live Updates
AZD1390 Demonstrates Initial Safety, May Enhance Radiotherapy Efficacy in Glioblastoma : vimarsana.com
AZD1390 Demonstrates Initial Safety, May Enhance Radiotherapy Efficacy in Glioblastoma : vimarsana.com
AZD1390 Demonstrates Initial Safety, May Enhance Radiotherapy Efficacy in Glioblastoma
Early safety and efficacy data seen with AZD1390 in a phase 1 study indicate it's potential utility as a radiosensitizing treatment in glioblastoma.
Related Keywords
Jonathant Yang ,
,
Memorial Sloan Kettering Cancer Center ,
News ,
Conference ,
Aacr ,
Glioblastoma ,
Azd1390 ,